This was not surprising, because WIP1 gene amplification/overexpression has been detected in adenocarcinomas of the breast, ovary, and pancreas, in gastric carcinomas, and in other cancers, where it was usually associated with poor prognosis (review in [15]). The gene discussed is PPM1D; the disease is gastric carcinoma.